CpG motifs: the active ingredient in bacterial extracts?
Related Experiment Video
Updated: Jun 27, 2026

Capture Compound Mass Spectrometry - A Powerful Tool to Identify Novel c-di-GMP Effector Proteins
Published on: March 29, 2015
1Coley Pharmaceutical Group, Wellesley, Massachusetts 02481, USA. akrieg@coleypharma.com
Abstract:
The use of bacteria and bacterial extracts for immunotherapy has a checkered past. Recent developments in immunology reveal that these nonspecific immune activators actually work by triggering specific receptors that are expressed by subsets of immune cells. Identification of these receptors and the molecular signaling pathways that they activate has enabled a new era of specific targeted immunotherapy using chemically synthesized mimics of pathogen molecules.
More Related Videos
Related Concept Videos
Antibiotic Selection
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
The Eukaryotic Promoter Region
GPCRs Regulate Adenylyl Cylase Activity
Two...
IP3/DAG Signaling Pathway
Stringent Response in E. coli

